ProShares UltraShort Health Care
3 hedge funds and large institutions have $18.1K invested in ProShares UltraShort Health Care in 2022 Q4 according to their latest regulatory filings, with 2 funds opening new positions, increasing their positions, 1 reducing their positions, and 2 closing their positions.
47% more call options, than puts
Call options by funds: $144M | Put options by funds: $97.8M
0% more funds holding
Funds holding: 3 → 3 (0)
0% more first-time investments, than exits
New positions opened: 2 | Existing positions closed: 2
2.81% less ownership
Funds ownership: 3.41% → 0.6% (-2.8%)
97% less capital invested
Capital invested by funds: $628K → $18.1K (-$610K)
100% less repeat investments, than reductions
Existing positions increased: 0 | Existing positions reduced: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
+$19.3K |
| 2 |
Simplex Trading
Chicago,
Illinois
|
+$483 |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$326K |
| 2 |
Envestnet Asset Management
Chicago,
Illinois
|
-$298K |
| 3 |
JP Morgan Chase
New York
|
-$3.5K |
RXD Hedge Fund Activity: Q4 2022 in Review
3 of the 6,237 institutional investors tracked by Wall St. Rank reported a position in ProShares UltraShort Health Care (RXD) for Q4 2022, worth a combined $18.1K — down 97% from $628K a quarter earlier.
Fund positioning in RXD was balanced in Q4 2022: 2 funds opened new positions, 2 closed out, 0 added to existing stakes and 1 trimmed.
The largest buyer was UBS Group, opening a new position worth an estimated $19.3K. The largest seller was Citadel Advisors, exiting entirely with an estimated $326K sold.
- 3 institutional investors held ProShares UltraShort Health Care (RXD) as of Q4 2022, unchanged from Q3 2022.
- Funds reported $18.1K of ProShares UltraShort Health Care stock for Q4 2022, down 97% quarter-over-quarter.
- 2 funds opened new ProShares UltraShort Health Care positions in Q4 2022 and 2 closed out, a net change of 0 holders.
- The largest ProShares UltraShort Health Care buyer in Q4 2022 was UBS Group, an estimated $19.3K added.
- The largest ProShares UltraShort Health Care seller in Q4 2022 was Citadel Advisors, an estimated $326K sold.
Based on aggregated 13F filings for Q4 2022.